Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis

被引:54
作者
Flamini, G
Curigliano, G
Ratto, C
Astone, A
Ferretti, G
Nucera, P
Sofo, L
Sgambato, A
Boninsegna, A
Crucitti, F
Cittadini, A
机构
[1] CATHOLIC UNIV,SCH MED,CTR RIC ONCOL GIOVANNI XXIII,INST GEN SURG,ROME,ITALY
[2] CATHOLIC UNIV,SCH MED,CTR RIC ONCOL GIOVANNI XXIII,INST INTERNAL MED,ROME,ITALY
关键词
p53; protein; cytoplasm; colorectal cancer; prognosis; immunohistochemistry;
D O I
10.1016/0959-8049(95)00625-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
p53 overexpression was studied by immunohistochemistry in 96 consecutive colorectal cancer patients, subdividing positive specimens according to two staining patterns: cytoplasmic or nuclear. Forty-seven per cent of the cases were p53 positive, a significant correlation being found with Dukes' stage (P = 0.0036). A prevalence of nuclear staining was observed in Dukes' B and cytoplasmic in Dukes' D stages. After 36 months, 23% of the patients had a recurrence, and 45% were p53 positive, all Dukes' C-D stage with cytoplasmic staining. The Kaplan-Meier curve showed a significant correlation between p53 cytoplasmic staining and disease-fi ee survival period (P = 0.002). With respect to disease-fi ee survival, the Cox proportional hazard regression test, comparing p53 positivity with Dukes' stage, showed the latter to be the most significant variable. In our series of patients, advanced Dukes' stage tumours were localised in the right colon, where a higher percentage of p53 positivity (67% versus 40% of the left side), as well as a higher frequency of cytoplasmic staining was observed. In conclusion, from the data obtained, a strong correlation between pS3 cytoplasmic staining and patient prognosis is clearly indicated. Copyright (C) 1996 Elsevier Science Ltd
引用
收藏
页码:802 / 806
页数:5
相关论文
共 32 条
[11]   DECREASED EXPRESSION OF DCC MESSENGER-RNA IN HUMAN COLORECTAL CANCERS [J].
ITOH, F ;
HINODA, Y ;
OHE, M ;
OHE, Y ;
BAN, T ;
ENDO, T ;
IMAI, K ;
YACHI, A .
INTERNATIONAL JOURNAL OF CANCER, 1993, 53 (02) :260-263
[12]  
JERRY DJ, 1993, CANCER RES, V53, P3374
[13]   IDENTIFICATION OF A GENE LOCATED AT CHROMOSOME-5Q21 THAT IS MUTATED IN COLORECTAL CANCERS [J].
KINZLER, KW ;
NILBERT, MC ;
VOGELSTEIN, B ;
BRYAN, TM ;
LEVY, DB ;
SMITH, KJ ;
PREISINGER, AC ;
HAMILTON, SR ;
HEDGE, P ;
MARKHAM, A ;
CARLSON, M ;
JOSLYN, G ;
GRODEN, J ;
WHITE, R ;
MIKI, Y ;
MIYOSHI, Y ;
NISHISHO, I ;
NAKAMURA, Y .
SCIENCE, 1991, 251 (4999) :1366-1370
[14]   CANCER - P53, GUARDIAN OF THE GENOME [J].
LANE, DP .
NATURE, 1992, 358 (6381) :15-16
[15]  
MIDGLEY CA, 1992, J CELL SCI, V101, P185
[16]   WILD-TYPE P53 PROTEIN UNDERGOES CYTOPLASMIC SEQUESTRATION IN UNDIFFERENTIATED NEUROBLASTOMAS BUT NOT IN DIFFERENTIATED TUMORS [J].
MOLL, UM ;
LAQUAGLIA, M ;
BENARD, J ;
RIOU, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (10) :4407-4411
[17]   2 DISTINCT MECHANISMS ALTER P53 IN BREAST-CANCER - MUTATION AND NUCLEAR EXCLUSION [J].
MOLL, UM ;
RIOU, G ;
LEVINE, AJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (15) :7262-7266
[18]   IMMUNOHISTOCHEMICAL DETECTION OF P53-PROTEINS AND BCL-2-PROTEINS IN NON-HODGKINS-LYMPHOMA [J].
PEZZELLA, F ;
MORRISON, H ;
JONES, M ;
GATTER, KC ;
LANE, D ;
HARRIS, AL ;
MASON, DY .
HISTOPATHOLOGY, 1993, 22 (01) :39-44
[19]   P53 MUTATIONS IN COLORECTAL-CANCER [J].
RODRIGUES, NR ;
ROWAN, A ;
SMITH, MEF ;
KERR, IB ;
BODMER, WF ;
GANNON, JV ;
LANE, DP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1990, 87 (19) :7555-7559
[20]   P53 IN COLORECTAL-CANCER - CLINICOPATHOLOGICAL CORRELATION AND PROGNOSTIC-SIGNIFICANCE [J].
SCOTT, N ;
SAGAR, P ;
STEWART, J ;
BLAIR, GE ;
DIXON, MF ;
QUIRKE, P .
BRITISH JOURNAL OF CANCER, 1991, 63 (02) :317-319